DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Yanai H, Lichtenstein L, Assa A. et al.
Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab.
Clin Gastroenterol Hepatol 2015;
13: 522-530 e2
We do not assume any responsibility for the contents of the web pages of other providers.